Dr. Kain is the Director of Drug Monitoring and Toxicology and Medical Science Liaison at Quest Diagnostics. He has served as a consultant, clinical toxicologist and medical science liaison for multiple toxicology laboratories. Dr. Kain has developed solutions that identify and incorporate drug-drug interaction analytics into drug testing platforms. Furthermore, he provides toxicology and clinical drug testing education for team members and stakeholders that are addressing the opioid epidemic across the nation.
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leader in diagnostic information services, today announced the availability of the first...
Scientists and the general public are increasingly aware that PFAS may be dangerous to human health, but access to quality, convenient testing to assess exposure is limited. Our PFAS blood test is based on the latest science and aligns with several facets of new CDC guidance as well as recommendations from the National Academies of Sciences, Engineering, and Medicine. Not everyone needs a PFAS test, but people at high risk of elevated exposure may benefit from greater access to the insights provided by this novel test.